124 related articles for article (PubMed ID: 37944428)
1. IL-27p28 specifically regulates MHC II expression in macrophages through CIITA.
Han Y; Zhang X; Wang Q; Cui X; Wang H; Zhang X; Wang Q; Ji J; Wang Y; Wang S; Zhang X; Xu H; Qiao M; Wu Z
Immunobiology; 2023 Nov; 228(6):152757. PubMed ID: 37944428
[TBL] [Abstract][Full Text] [Related]
2. SYK regulates macrophage MHC-II expression via activation of autophagy in response to oxidized LDL.
Choi SH; Gonen A; Diehl CJ; Kim J; Almazan F; Witztum JL; Miller YI
Autophagy; 2015; 11(5):785-95. PubMed ID: 25946330
[TBL] [Abstract][Full Text] [Related]
3.
Letendre C; Auger JP; Lemire P; Galbas T; Gottschalk M; Thibodeau J; Segura M
Front Immunol; 2018; 9():1199. PubMed ID: 29899744
[No Abstract] [Full Text] [Related]
4. Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I INDUCTION REGULATES ANTIGEN PRESENTATION BY MACROPHAGES BUT NOT DENDRITIC CELLS.
Mittal SK; Cho KJ; Ishido S; Roche PA
J Biol Chem; 2015 Nov; 290(45):27158-27167. PubMed ID: 26408197
[TBL] [Abstract][Full Text] [Related]
5. Critical role of the tumor suppressor tuberous sclerosis complex 1 in dendritic cell activation of CD4 T cells by promoting MHC class II expression via IRF4 and CIITA.
Pan H; O'Brien TF; Wright G; Yang J; Shin J; Wright KL; Zhong XP
J Immunol; 2013 Jul; 191(2):699-707. PubMed ID: 23776173
[TBL] [Abstract][Full Text] [Related]
6. Class I myosin Myo1e regulates TLR4-triggered macrophage spreading, chemokine release, and antigen presentation via MHC class II.
Wenzel J; Ouderkirk JL; Krendel M; Lang R
Eur J Immunol; 2015 Jan; 45(1):225-37. PubMed ID: 25263281
[TBL] [Abstract][Full Text] [Related]
7. MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity.
Benasciutti E; Mariani E; Oliva L; Scolari M; Perilli E; Barras E; Milan E; Orfanelli U; Fazzalari NL; Campana L; Capobianco A; Otten L; Particelli F; Acha-Orbea H; Baruffaldi F; Faccio R; Sitia R; Reith W; Cenci S
J Bone Miner Res; 2014 Feb; 29(2):290-303. PubMed ID: 24038328
[TBL] [Abstract][Full Text] [Related]
8.
Sengupta S; Naz S; Das I; Ahad A; Padhi A; Naik SK; Ganguli G; Pattanaik KP; Raghav SK; Nandicoori VK; Sonawane A
J Biol Chem; 2017 Apr; 292(17):6855-6868. PubMed ID: 28209712
[No Abstract] [Full Text] [Related]
9. Deletion of IL-27p28 induces CD8 T cell immunity against colorectal tumorigenesis.
Li P; Pu S; Yi J; Li X; Wu Q; Yang C; Kang M; Peng F; Zhou Z
Int Immunopharmacol; 2024 Feb; 128():111464. PubMed ID: 38224627
[TBL] [Abstract][Full Text] [Related]
10. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
Broxmeyer HE; Cooper S; Hangoc G; Chang CH
Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
[TBL] [Abstract][Full Text] [Related]
11. CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells.
Rocha-Perugini V; Martínez Del Hoyo G; González-Granado JM; Ramírez-Huesca M; Zorita V; Rubinstein E; Boucheix C; Sánchez-Madrid F
Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28533221
[TBL] [Abstract][Full Text] [Related]
12. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
[TBL] [Abstract][Full Text] [Related]
13. BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9.
Bakhru P; Sirisaengtaksin N; Soudani E; Mukherjee S; Khan A; Jagannath C
Cell Immunol; 2014 Jan; 287(1):53-61. PubMed ID: 24384074
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine Modulation of IL-27 in Macrophages.
Roewe J; Higer M; Riehl DR; Gericke A; Radsak MP; Bosmann M
J Immunol; 2017 Oct; 199(7):2503-2514. PubMed ID: 28835457
[TBL] [Abstract][Full Text] [Related]
15. Enhanced production of IL-10 by dendritic cells deficient in CIITA.
Yee CS; Yao Y; Xu Q; McCarthy B; Sun-Lin D; Tone M; Waldmann H; Chang CH
J Immunol; 2005 Feb; 174(3):1222-9. PubMed ID: 15661876
[TBL] [Abstract][Full Text] [Related]
16. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
17. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
Herrera OB; Brett S; Lechler RI
Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide inhibits INFgamma-induced increases in CIITA mRNA abundance and activation of CIITA dependent genes--class II MHC, Ii and H-2M. Class II TransActivator.
Kielar ML; Sicher SC; Penfield JG; Jeyarajah DR; Lu CY
Inflammation; 2000 Oct; 24(5):431-45. PubMed ID: 10921507
[TBL] [Abstract][Full Text] [Related]
19. IL-27p28 knockout aggravates Doxorubicin-induced cardiotoxicity by regulating Macrophage polarization.
Feng Y; Ji Q; Ye D; Pan H; Lu X; Gan L; Wang M; Liu J; Xu Y; Zhang J; Zhao M; Xu S; Yin Z; Pan W; Wei C; Liu M; Wan J; Ye J
Biochem Pharmacol; 2023 Apr; 210():115469. PubMed ID: 36868324
[TBL] [Abstract][Full Text] [Related]
20. Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases.
Yau AC; Piehl F; Olsson T; Holmdahl R
Immunology; 2017 Apr; 150(4):408-417. PubMed ID: 27861821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
